Medacta : Company Presentation

COMPANY PRESENTATION

An International High-Growth Platform With a New Approach to Orthopaedics

May 2022

DISCLAIMER

This presentation (the "Presentation") has been prepared by Medacta Group SA ("Medacta" and together with its subsidiaries, "we", "us" or the "Group"). The information contained in the Presentation does not purport to be comprehensive. Please refer to the financial reports available on our website at https://www.medacta.com/EN/investors.

Forward-looking information

This Presentation has been prepared by Medacta and may include forward-looking information and statements concerning the outlook for our business. These statements are based on current expectations, estimates and projections about the factors that may affect our future performance. These expectations, estimates and projections are generally identifiable by statements containing words such as "expects", "believes", "estimates", "targets", "plans", "outlook" or similar expressions.

There are numerous risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking information and statements made in this Presentation. The important factors that could cause such differences include: changes in the global economic conditions and the economic conditions of the regions and markets in which the Group operates; changes in healthcare regulations (in particular with regard to medical devices); the development of our customer base; the competitive environment in which the Group operates; manufacturing or logistics disruptions; the impact of fluctuations in foreign exchange rates; and such other factors as may be discussed from time to time. Although we believe that our expectations reflected in any such forward-looking statement are based upon reasonable assumptions, we can give no assurance that those expectations will be achieved.

Alternative Performance Measures

This Presentation may contain information regarding alternative performance measures. Definitions of these measures and reconciliations between such measures and their IFRS counterparts if not defined in the Presentation may be found on the financial reports available on our website at https://www.medacta.com/EN/investors.

THIS PRESENTATION IS NOT AN INVITATION TO PURCHASE SECURITIES OF MEDACTA OR THE GROUP

2

MEDACTA

SWISS COMPANY, GLOBAL PARTNER

Company Presentation

| Medacta | Innovative offering | Educational activities | Governance and Financials |

We are an international company specialized in the design, production and distribution of innovative orthopaedic products and accompanying surgical techniques for joint replacement, spine surgery and sports medicine.

|Medacta | Innovative Offering | Medical Education | Governance, Financials and ESG |

4

Innovation is the foundation of our present and future success.

Our innovation began with minimally invasive techniques and has evolved into personalized solutions for every patient.

The goal of our innovation is to improve the well-beingof our patients through innovative solutions that promote healthcare sustainability.

INNOVATION

MEDICAL EDUCATION

Transforms innovation into concrete benefits

PATIENT	HEALTHCARE
WELL-BEING	SUSTAINABILITY

|Medacta | Innovative Offering | Medical Education | Governance, Financials and ESG |

5